Sorafenib Increases Efficacy of Vorinostat Against Human Hepatocellular Carcinoma Through Transduction Inhibition of Vorinostat-Induced ERK/NF-κB Signaling
International Journal of Oncology - Greece
doi 10.3892/ijo.2014.2423
Full Text
Open PDFAbstract
Available in full text
Date
May 6, 2014
Authors
Publisher
Spandidos Publications